Denmark· DK-28106866722
Alkacit
A potassium citrate product containing kaliumcitratmonohydrat, registered in Denmark by XGX Pharma ApS. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Potassium citrate is registered in 9 of 19 countries.
Countries holding a registration under ATC A12BA02 (potassium citrate), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 5 of them publish a price we can compare per daily dose
Potassium citrate · ATC A12BA02
9 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
Price per daily dose
What a daily dose of potassium citrate costs, country by country.
Normalised to the WHO defined daily dose (4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Potassium citrate · price per daily dose (4 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.74
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Kaliumcitratmonohydrat
- Manufacturer
- XGX Pharma ApS
- Country
- Denmark (DK)
- ATC code
- A12BA02
- ATC class
- Potassium citrate
- Defined daily dose
- 4 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106866722
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
201 interactions on record for potassium citrate.
Graded by severity as the source publishes them — 108 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Potassium citrate · interactions on record
201 records
- 108 severe
- 67 moderate
- 26 minor
Most severe, free to view
- DicycloverineA03AA07severe
- PropanthelineA03AB05severe
- MepenzolateA03AB12severe
- TrospiumA03AB20severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A12BA02
Potassium citrate, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e9f583e8-e129-4dad-82c8-2b4626f2094e GET /v1/drugs/e9f583e8-e129-4dad-82c8-2b4626f2094e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tabletter med modificeret udløsning",
"source": "dkma",
"strength": "10 mEq",
"auth_role": "RMS",
"dk_drugid": "28106866722",
"substance": "Kaliumcitratmonohydrat",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "45335"
}See everything about potassium citrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.